Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.40284 | 55 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.29307 | 53 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.29901 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.17383 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.6762 | 62 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.48542 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.43194 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.39991 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.25473 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.25055 | 52 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.30126 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.2298 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.32679 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.29734 | 53 |